McKesson (MCK) Financials

McKesson logo
$1,105.77 +2.96 (+0.27%)
Closing price 03:59 PM Eastern
Extended Trading
$1,104.73 -1.04 (-0.09%)
As of 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for McKesson

Annual Income Statements for McKesson

This table shows McKesson's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
2,258 5,070 67 34 900 -4,539 1,114 3,560 3,002 3,295 4,762
Consolidated Net Income / (Loss)
2,310 5,153 297 255 1,120 -4,340 1,287 3,722 3,160 3,481 5,099
Net Income / (Loss) Continuing Operations
2,342 5,277 292 254 1,126 -4,339 1,292 3,725 3,160 3,481 5,099
Total Pre-Tax Income
3,250 6,891 239 610 1,144 -5,034 1,928 4,630 3,789 4,359 6,201
Total Operating Income
3,545 7,122 762 886 2,489 -5,040 2,038 4,381 3,909 4,422 6,212
Total Gross Profit
11,416 11,271 11,184 11,754 12,023 12,148 13,130 12,358 12,828 13,323 14,550
Total Revenue
190,884 198,533 208,357 214,319 231,051 238,228 263,966 276,711 308,951 359,051 403,430
Operating Revenue
190,884 198,533 208,357 214,319 231,051 238,228 263,966 276,711 308,951 359,051 403,430
Total Cost of Revenue
179,468 187,262 197,173 202,565 219,028 226,080 250,836 264,353 296,123 345,728 388,880
Operating Cost of Revenue
179,468 187,262 197,173 202,565 219,028 226,080 250,836 264,353 296,123 345,728 388,880
Total Operating Expenses
7,871 4,149 10,422 10,868 9,534 17,188 11,092 7,977 8,919 8,901 8,338
Selling, General & Admin Expense
7,379 7,447 8,138 8,437 9,182 8,849 10,537 7,776 8,657 8,507 8,096
Restructuring Charge
203 18 567 597 268 334 281 209 115 286 245
Other Special Charges / (Income)
- 0.00 -146 37 82 7,936 274 -8.00 147 108 -3.00
Total Other Income / (Expense), net
-295 -231 -523 -276 -1,345 6.00 -110 249 -120 -63 -11
Interest Expense
353 308 405 264 249 217 369 248 252 265 247
Other Income / (Expense), net
58 77 -118 182 12 223 259 497 132 202 236
Income Tax Expense
908 1,614 -53 356 18 -695 636 905 629 878 1,102
Net Income / (Loss) Attributable to Noncontrolling Interest
52 83 230 221 220 199 173 162 158 186 337
Basic Earnings per Share
$9.82 $22.95 $0.32 $0.17 $4.98 ($28.26) $7.32 $25.23 $22.54 $25.86 $38.55
Weighted Average Basic Shares Outstanding
230M 221M 208M 196.30M 180.60M 160.60M 152.30M 141.10M 133.20M 127.40M 123.60M
Diluted Earnings per Share
$9.70 $22.73 $0.32 $0.17 $4.95 ($28.26) $7.23 $25.03 $22.39 $25.72 $38.38
Weighted Average Diluted Shares Outstanding
233M 223M 209M 197.30M 181.60M 160.60M 154.10M 142.20M 134.10M 128.10M 124.10M
Weighted Average Basic & Diluted Shares Outstanding
229.90M 220.90M 209.40M 200M 161.85M 158.19M 145.37M 135.60M 129.99M 125.11M 120.20M
Cash Dividends to Common per Share
$1.08 $1.12 $1.30 $1.51 $1.62 $1.67 $1.83 $2.09 $2.40 $2.75 $3.17

Quarterly Income Statements for McKesson

This table shows McKesson's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 2,135 - - - 2,352
Net Income / (Loss) Attributable to Common Shareholders
791 915 241 879 1,260 784 1,110 1,186 1,682 614 1,218
Consolidated Net Income / (Loss)
830 960 287 928 1,306 831 1,163 1,250 1,855 1,032 1,296
Net Income / (Loss) Continuing Operations
830 960 287 928 1,306 831 1,163 1,250 1,855 1,032 1,296
Total Pre-Tax Income
1,170 1,084 534 1,226 1,515 1,051 1,395 1,630 2,125 1,308 1,562
Total Operating Income
1,216 1,029 578 1,224 1,591 1,036 1,407 1,619 2,150 1,319 1,604
Total Gross Profit
3,585 3,152 3,248 3,284 3,639 3,279 3,542 3,685 4,044 3,685 3,956
Total Revenue
76,355 79,283 93,651 95,294 90,823 97,827 103,150 106,158 96,295 105,380 110,957
Operating Revenue
76,355 79,283 93,651 95,294 90,823 97,827 103,150 106,158 96,295 105,380 110,957
Total Cost of Revenue
72,770 76,131 90,403 92,010 87,184 94,548 99,608 102,473 92,251 101,695 107,001
Operating Cost of Revenue
72,770 76,131 90,403 92,010 87,184 94,548 99,608 102,473 92,251 101,695 107,001
Total Operating Expenses
2,369 2,123 2,670 2,060 2,048 2,243 2,135 2,066 1,894 2,366 2,352
Selling, General & Admin Expense
2,189 2,001 2,503 2,028 1,975 2,196 2,074 2,030 1,796 2,264 2,269
Restructuring Charge
31 10 171 32 73 47 63 36 99 136 85
Other Special Charges / (Income)
149 112 -4.00 0.00 - 0.00 -2.00 0.00 -1.00 -34 -2.00
Total Other Income / (Expense), net
-46 55 -44 2.00 -76 15 -12 11 -25 -11 -42
Interest Expense
80 75 78 67 45 49 74 63 61 77 105
Other Income / (Expense), net
34 130 34 69 -31 64 62 74 36 66 63
Income Tax Expense
340 124 247 298 209 220 232 380 270 276 266
Net Income / (Loss) Attributable to Noncontrolling Interest
39 45 46 49 46 47 53 64 173 418 78
Basic Earnings per Share
$6.07 $7.04 $1.88 $6.98 $9.96 $6.28 $8.95 $9.63 $13.69 $5.17 $10.47
Weighted Average Basic Shares Outstanding
133.20M 129.80M 128.70M 126M 127.40M 124.90M 124M 123.20M 123.60M 118.70M 116.30M
Diluted Earnings per Share
$6.03 $7.00 $1.87 $6.95 $9.90 $6.25 $8.92 $9.59 $13.62 $5.15 $10.44
Weighted Average Diluted Shares Outstanding
134.10M 130.70M 129.30M 126.60M 128.10M 125.50M 124.40M 123.70M 124.10M 119.20M 116.70M
Weighted Average Basic & Diluted Shares Outstanding
129.99M 129.68M 126.94M 125.33M 125.11M 124.38M 123.43M 122.49M 120.20M 116.59M 115.46M

Annual Cash Flow Statements for McKesson

This table details how cash moves in and out of McKesson's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents
-1,293 -594 -1,732 309 1,042 2,373 -2,461 744 -94 1,371 -1,888
Net Cash From Operating Activities
3,672 4,744 4,345 4,036 4,374 4,542 4,434 5,159 4,314 6,085 6,155
Net Cash From Continuing Operating Activities
3,672 4,744 4,345 4,036 4,374 4,542 4,434 5,159 4,314 6,085 6,155
Net Income / (Loss) Continuing Operations
2,310 5,153 297 255 1,120 -4,340 1,287 3,722 3,160 3,481 5,099
Consolidated Net Income / (Loss)
2,310 5,153 297 255 1,120 -4,340 1,287 3,722 3,160 3,481 5,099
Depreciation Expense
281 324 303 317 321 321 279 248 253 242 256
Amortization Expense
604 586 648 632 601 566 481 360 382 394 473
Non-Cash Adjustments To Reconcile Net Income
380 -3,517 2,227 2,029 1,985 717 2,271 409 1,149 1,204 -65
Changes in Operating Assets and Liabilities, net
97 2,198 870 803 347 7,278 116 420 -630 764 392
Net Cash From Investing Activities
-1,557 -3,269 -2,993 -1,381 -579 -415 -89 -542 -1,072 -733 -3,432
Net Cash From Continuing Investing Activities
-1,767 -3,269 -2,993 -1,381 -579 -415 -89 -542 -1,072 -733 -3,432
Purchase of Property, Plant & Equipment
-488 -404 -405 -426 -362 -451 -388 -390 -431 -537 -436
Acquisitions
-229 -4,370 -3,068 -1,036 -277 -225 -153 -1,035 -528 -346 -3,725
Divestitures
0.00 206 500 101 37 400 578 1,077 47 179 830
Other Investing Activities, net
-1,050 1,299 -20 -20 23 -139 -126 -194 -160 -29 -101
Net Cash From Financing Activities
-3,453 -2,069 -3,084 -2,227 -2,734 -1,693 -6,321 -4,368 -3,342 -3,965 -4,631
Net Cash From Continuing Financing Activities
-3,453 -2,069 -3,084 -2,227 -2,734 -1,693 -6,321 -4,368 -3,342 -3,965 -4,631
Repayment of Debt
-3,281 -9,743 -23,309 -38,735 -22,053 -7,541 -13,407 -10,048 -20,427 -16,159 -10,826
Repurchase of Common Equity
-1,612 -2,311 -1,709 -1,639 -1,937 -791 -4,547 -3,638 -3,025 -3,146 -4,750
Payment of Dividends
-244 -253 -262 -292 -294 -276 -277 -292 -314 -345 -381
Issuance of Debt
1,561 10,118 22,064 38,364 21,437 6,823 11,690 9,447 20,955 15,584 11,237
Issuance of Common Equity
123 120 132 75 113 92 220 163 116 101 89
Other Financing Activities, net
- - - - - - 0.00 0.00 -647 0.00 0.00
Effect of Exchange Rate Changes
45 - - -119 -19 -61 55 25 6.00 -16 20
Cash Interest Paid
337 315 298 383 235 220 186 224 234 273 212
Cash Income Taxes Paid
923 587 144 262 368 379 359 562 901 1,124 1,211

Quarterly Cash Flow Statements for McKesson

This table details how cash moves in and out of McKesson's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
2,602 -2,281 207 -1,229 4,674 -3,273 1,426 -1,056 1,015 1,188 1,363
Net Cash From Operating Activities
4,147 -1,380 2,100 -2,383 7,748 -918 2,420 1,232 3,421 -220 3,070
Net Cash From Continuing Operating Activities
4,147 -1,380 2,100 -2,383 7,748 -918 2,420 1,232 3,421 -220 3,070
Net Income / (Loss) Continuing Operations
830 960 287 928 1,306 831 1,163 1,250 1,855 1,032 1,296
Consolidated Net Income / (Loss)
830 960 287 928 1,306 831 1,163 1,250 1,855 1,032 1,296
Depreciation Expense
62 63 61 58 60 62 62 65 67 69 70
Amortization Expense
98 106 102 95 91 95 126 123 129 126 127
Non-Cash Adjustments To Reconcile Net Income
-54 56 683 246 219 335 107 -71 -436 226 171
Changes in Operating Assets and Liabilities, net
3,211 -2,565 967 -3,710 6,072 -2,241 962 -135 1,806 -1,673 1,406
Net Cash From Investing Activities
-577 -87 -286 -136 -224 -3,564 -24 -269 425 -214 -130
Net Cash From Continuing Investing Activities
-577 -87 -286 -136 -224 -3,564 -24 -269 425 -214 -130
Purchase of Property, Plant & Equipment
-188 -106 -136 -126 -169 -111 -106 -108 -111 -112 -65
Acquisitions
-347 -61 -83 -72 -130 -3,437 -120 -90 -78 -63 -58
Divestitures
- 90 3.00 -10 96 4.00 129 4.00 693 9.00 20
Other Investing Activities, net
-42 -10 -70 72 -21 -20 73 -75 -79 -48 -27
Net Cash From Financing Activities
-968 -809 -1,599 1,298 -2,855 1,176 -961 -2,026 -2,820 1,632 -1,574
Net Cash From Continuing Financing Activities
-968 -809 -1,599 1,298 -2,855 1,176 -961 -2,026 -2,820 1,632 -1,574
Repayment of Debt
-15,443 -1,583 -6,072 -2,321 -6,183 -165 -2,357 -1,260 -7,044 -212 -617
Repurchase of Common Equity
-678 -527 -1,492 -827 -300 -581 -818 -680 -2,671 -2,530 -894
Payment of Dividends
-82 -82 -80 -92 -91 -90 -89 -101 -101 -102 -96
Issuance of Common Equity
41 22 32 19 28 22 28 15 24 23 33
Effect of Exchange Rate Changes
- -5.00 6.00 -22 5.00 33 -9.00 7.00 -11 -10 -3.00

Annual Balance Sheets for McKesson

This table presents McKesson's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets
56,523 60,969 60,381 59,672 61,247 65,015 63,298 62,320 67,443 75,140 82,323
Total Current Assets
38,435 36,948 37,136 38,465 42,222 45,382 46,231 44,292 47,970 55,398 57,210
Cash & Equivalents
4,048 2,783 2,672 2,981 4,015 6,278 3,532 4,678 4,583 5,691 3,975
Accounts Receivable
17,980 18,215 17,711 18,246 19,950 19,181 18,583 19,410 21,622 25,643 27,985
Inventories, net
15,335 15,278 16,310 16,709 16,734 19,246 18,702 19,691 21,139 23,001 24,207
Prepaid Expenses
1,072 672 443 529 617 665 898 513 626 1,063 1,043
Plant, Property, & Equipment, net
2,278 2,292 2,464 2,548 2,365 2,581 2,092 2,177 2,316 2,502 2,668
Total Noncurrent Assets
15,810 21,729 20,781 18,659 16,660 17,052 14,975 15,851 17,157 17,240 22,445
Goodwill
9,786 10,586 10,924 9,358 9,360 9,493 9,451 9,947 10,132 10,022 11,316
Intangible Assets
3,021 3,665 4,102 3,689 3,156 2,878 2,059 2,277 2,110 1,464 4,079
Other Noncurrent Operating Assets
3,003 3,415 2,027 2,099 4,144 4,681 3,465 3,627 4,915 5,754 7,050
Total Liabilities & Shareholders' Equity
56,523 60,969 60,381 59,672 61,247 65,015 63,298 62,320 67,443 75,140 82,323
Total Liabilities
46,109 48,369 48,865 49,992 54,536 63,569 65,090 63,810 69,042 76,834 83,157
Total Current Liabilities
35,069 35,612 36,685 37,626 42,624 44,103 48,466 47,957 52,357 61,604 67,017
Short-Term Debt
1,617 1,240 1,129 330 1,052 742 799 968 50 1,191 1,267
Accounts Payable
28,585 31,022 32,177 33,853 37,195 38,975 38,086 42,490 47,097 55,330 59,973
Accrued Expenses
3,948 3,004 3,379 3,443 3,340 3,987 4,543 4,200 4,915 4,825 5,490
Other Current Liabilities
- - - - 354 390 297 299 295 258 287
Total Noncurrent Liabilities
11,040 12,757 12,180 12,366 11,912 19,466 16,624 15,853 16,685 15,230 16,140
Long-Term Debt
6,497 7,305 6,751 7,265 6,335 6,406 5,080 4,626 5,579 4,463 5,259
Asset Retirement Reserve & Litigation Obligation
- - - - 0.00 8,067 7,220 6,625 6,113 5,601 5,091
Noncurrent Deferred & Payable Income Tax Liabilities
2,734 3,678 2,804 2,998 2,255 1,411 1,418 1,387 917 1,029 1,330
Other Noncurrent Operating Liabilities
1,809 1,774 2,625 2,103 3,322 3,582 2,906 3,215 4,076 4,137 4,460
Redeemable Noncontrolling Interest
1,406 1,327 1,459 1,393 1,402 1,271 - - - 0.00 943
Total Equity & Noncontrolling Interests
9,008 11,273 10,057 8,287 5,309 175 -1,792 -1,490 -1,599 -1,694 -1,777
Total Preferred & Common Equity
8,924 11,095 9,804 8,094 5,092 -21 -2,272 -1,857 -1,971 -2,074 -2,172
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
8,924 11,095 9,804 8,094 5,092 -21 -2,272 -1,857 -1,971 -2,074 -2,172
Common Stock
5,848 6,031 6,191 6,438 6,665 6,927 7,277 7,750 8,051 8,376 8,287
Retained Earnings
8,360 13,189 12,986 12,409 13,022 8,202 9,030 12,295 14,978 17,921 22,291
Treasury Stock
-3,721 -5,982 -7,655 -8,902 -12,892 -13,670 -17,045 -20,997 -24,119 -27,439 -32,005
Accumulated Other Comprehensive Income / (Loss)
-1,561 -2,141 -1,717 -1,849 -1,703 -1,480 -1,534 -905 -881 -932 -745
Noncontrolling Interest
84 178 253 193 217 196 480 367 372 380 395

Quarterly Balance Sheets for McKesson

This table presents McKesson's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025 6/30/2026 9/30/2026
Total Assets
66,091 66,512 67,443 71,670 72,429 71,081 81,311 84,160 84,190 88,330 92,323
Total Current Assets
47,531 47,640 47,970 52,252 53,341 51,741 56,801 59,887 59,697 62,837 66,685
Cash & Equivalents
2,524 1,982 4,583 2,302 2,509 1,131 2,418 4,004 2,959 5,164 6,528
Accounts Receivable
22,494 23,066 21,622 23,743 25,270 25,831 28,158 28,286 28,213 30,316 30,806
Inventories, net
21,945 22,020 21,139 25,571 24,176 23,837 25,065 26,134 27,067 26,259 28,217
Prepaid Expenses
568 572 626 636 751 942 1,160 1,463 1,458 1,098 1,134
Plant, Property, & Equipment, net
2,171 2,201 2,316 2,357 2,361 2,397 2,574 2,627 2,634 2,684 2,665
Total Noncurrent Assets
16,389 16,671 17,157 17,061 16,727 16,943 21,936 21,646 21,859 22,809 22,973
Goodwill
9,934 9,973 10,132 10,118 10,087 10,004 11,365 11,283 11,324 11,278 11,272
Intangible Assets
2,142 2,097 2,110 2,045 1,573 1,509 4,272 4,220 4,179 4,013 3,942
Other Noncurrent Operating Assets
4,313 4,601 4,915 4,898 5,067 5,430 6,299 6,143 6,356 7,518 7,759
Total Liabilities & Shareholders' Equity
66,091 66,512 67,443 71,670 72,429 71,081 81,311 84,160 84,190 88,330 92,323
Total Liabilities
67,555 68,194 69,042 73,051 75,071 73,785 82,174 84,738 84,289 89,631 93,339
Total Current Liabilities
51,147 51,661 52,357 56,434 58,771 58,562 64,331 68,031 68,131 70,356 74,396
Short-Term Debt
49 266 50 51 53 3,590 1,249 1,747 1,132 1,297 794
Accounts Payable
46,795 46,699 47,097 51,704 53,317 49,689 57,861 60,938 60,683 63,731 67,761
Accrued Expenses
4,007 4,400 4,915 4,383 4,787 5,027 4,924 5,068 6,030 5,036 5,555
Other Current Liabilities
296 296 295 296 243 256 297 278 286 292 286
Total Noncurrent Liabilities
16,408 16,533 16,685 16,617 16,300 15,223 17,843 16,707 16,158 19,275 18,943
Long-Term Debt
5,535 5,625 5,579 5,584 5,691 4,422 6,528 6,011 5,425 8,432 8,414
Asset Retirement Reserve & Litigation Obligation
6,128 6,128 6,113 6,114 5,617 5,617 5,601 5,103 5,103 5,058 4,563
Noncurrent Deferred & Payable Income Tax Liabilities
1,112 978 917 928 1,048 1,092 987 1,086 1,108 1,363 1,457
Other Noncurrent Operating Liabilities
3,633 3,802 4,076 3,991 3,944 4,092 4,727 4,507 4,522 4,422 4,509
Redeemable Noncontrolling Interest
- - - - - - 725 777 802 2,563 2,563
Total Equity & Noncontrolling Interests
-1,464 -1,682 -1,599 -1,381 -2,642 -2,704 -1,588 -1,355 -901 -3,864 -3,579
Total Preferred & Common Equity
-1,828 -2,053 -1,971 -1,755 -3,017 -3,084 -1,967 -1,739 -1,298 -4,240 -3,954
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-1,828 -2,053 -1,971 -1,755 -3,017 -3,084 -1,967 -1,739 -1,298 -4,240 -3,954
Common Stock
7,902 7,965 8,051 8,129 8,224 8,294 8,452 8,502 8,549 8,591 8,910
Retained Earnings
13,761 14,268 14,978 15,810 15,959 16,752 18,616 19,622 20,710 22,808 23,916
Treasury Stock
-22,604 -23,474 -24,119 -24,781 -26,310 -27,141 -28,137 -28,955 -29,654 -34,890 -36,012
Accumulated Other Comprehensive Income / (Loss)
-887 -812 -881 -913 -890 -989 -898 -908 -903 -749 -768
Noncontrolling Interest
364 371 372 374 375 380 379 384 397 376 375

Annual Metrics And Ratios for McKesson

This table displays calculated financial ratios and metrics derived from McKesson's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 122,487,456.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 122,487,456.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 38.88
Growth Metrics
- - - - - - - - - - -
Revenue Growth
6.61% 4.01% 4.95% 2.86% 7.81% 3.11% 10.80% 4.83% 11.65% 16.22% 12.36%
EBITDA Growth
10.87% 80.68% -80.33% 26.46% 69.71% -214.81% 177.79% 79.46% -14.76% 12.49% 36.44%
EBIT Growth
18.87% 99.81% -91.05% 65.84% 134.18% -292.60% 147.69% 112.36% -17.16% 14.43% 39.45%
NOPAT Growth
24.15% 113.49% -82.93% -60.37% 564.05% -244.01% 138.71% 158.08% -7.51% 8.32% 44.65%
Net Income Growth
49.71% 123.07% -94.24% -14.14% 339.22% -487.50% 129.65% 189.20% -15.10% 10.16% 46.48%
EPS Growth
54.70% 134.33% -98.59% -46.88% 2,811.76% -670.91% 125.58% 246.20% -10.55% 14.87% 49.22%
Operating Cash Flow Growth
17.99% 29.19% -8.41% -7.11% 8.37% 3.84% -2.38% 16.35% -16.38% 41.05% 1.15%
Free Cash Flow Firm Growth
-57.34% 175.06% -60.35% 15.66% 30.45% 19.23% -27.87% 68.30% -33.61% 45.39% -64.75%
Invested Capital Growth
3.62% -1.25% -9.11% -17.04% -8.54% -76.54% -66.28% -173.59% 3.66% -213.02% 199.19%
Revenue Q/Q Growth
0.93% 1.04% 1.42% 0.38% 2.71% 0.26% 2.71% 1.03% 2.47% 4.20% 1.38%
EBITDA Q/Q Growth
19.71% 133.29% -76.94% 167.15% 273.69% 4.26% -12.83% 6.19% 5.36% 6.07% 10.31%
EBIT Q/Q Growth
1.26% 124.76% -90.18% 145.52% 132.87% 3.70% -14.55% 7.04% 6.29% 7.19% 10.75%
NOPAT Q/Q Growth
1.97% 138.64% -82.68% 220.87% 232.99% 2.72% -18.25% 14.83% -0.13% 16.56% 11.03%
Net Income Q/Q Growth
14.93% 161.04% -94.07% 396.51% 259.54% -9.18% -19.31% 12.75% 0.13% 15.84% 12.07%
EPS Q/Q Growth
15.89% 168.68% -98.54% 113.71% 203.56% -4.28% -21.84% 14.66% 1.54% 17.71% 10.73%
Operating Cash Flow Q/Q Growth
49.94% -26.05% 57.66% 27.52% 21.00% -22.04% -9.82% 9.28% 23.54% 144.97% -41.28%
Free Cash Flow Firm Q/Q Growth
-37.53% 66.15% -44.71% 529.04% 17.92% -12.24% -34.38% 37.14% 22.91% 336.17% -68.55%
Invested Capital Q/Q Growth
-7.48% -1.68% -18.15% -28.89% -24.38% -52.14% -62.61% -135.92% -124.83% -141.44% -50.93%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
5.98% 5.68% 5.37% 5.48% 5.20% 5.10% 4.97% 4.47% 4.15% 3.71% 3.61%
EBITDA Margin
2.35% 4.08% 0.77% 0.94% 1.48% -1.65% 1.16% 1.98% 1.51% 1.47% 1.78%
Operating Margin
1.86% 3.59% 0.37% 0.41% 1.08% -2.12% 0.77% 1.58% 1.27% 1.23% 1.54%
EBIT Margin
1.89% 3.63% 0.31% 0.50% 1.08% -2.02% 0.87% 1.76% 1.31% 1.29% 1.60%
Profit (Net Income) Margin
1.21% 2.60% 0.14% 0.12% 0.48% -1.82% 0.49% 1.35% 1.02% 0.97% 1.26%
Tax Burden Percent
71.08% 74.78% 124.27% 41.80% 97.90% 86.21% 66.75% 80.39% 83.40% 79.86% 82.23%
Interest Burden Percent
90.20% 95.72% 37.11% 57.12% 45.74% 104.50% 83.94% 94.92% 93.76% 94.27% 96.17%
Effective Tax Rate
27.94% 23.42% -22.18% 58.36% 1.57% 0.00% 32.99% 19.55% 16.60% 20.14% 17.77%
Return on Invested Capital (ROIC)
17.96% 37.90% 6.82% 3.10% 23.74% -57.96% 88.31% 3,422.01% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
12.25% 27.46% -33.06% -5.72% -38.84% -98.40% 83.73% 3,433.33% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
5.28% 6.88% -4.36% -0.70% -10.07% -48.45% -832.24% -3,648.82% 0.00% 0.00% 0.00%
Return on Equity (ROE)
23.23% 44.78% 2.46% 2.41% 13.67% -106.41% -743.93% -226.81% -204.60% -211.42% -403.40%
Cash Return on Invested Capital (CROIC)
14.40% 39.16% 16.37% 21.73% 32.66% 66.03% 187.44% 0.00% 0.00% 0.00% 96.68%
Operating Return on Assets (OROA)
6.53% 12.25% 1.06% 1.78% 4.14% -7.63% 3.58% 7.77% 6.23% 6.49% 8.19%
Return on Assets (ROA)
4.19% 8.77% 0.49% 0.42% 1.85% -6.87% 2.01% 5.93% 4.87% 4.88% 6.48%
Return on Common Equity (ROCE)
19.78% 38.95% 2.13% 2.03% 10.99% -66.15% -4,930.15% -285.35% -253.54% -259.70% -677.55%
Return on Equity Simple (ROE_SIMPLE)
25.89% 46.44% 3.03% 3.15% 22.00% 0.00% -56.65% -200.43% -160.32% -167.84% 0.00%
Net Operating Profit after Tax (NOPAT)
2,555 5,454 931 369 2,450 -3,528 1,366 3,525 3,260 3,531 5,108
NOPAT Margin
1.34% 2.75% 0.45% 0.17% 1.06% -1.48% 0.52% 1.27% 1.06% 0.98% 1.27%
Net Nonoperating Expense Percent (NNEP)
5.71% 10.44% 39.89% 8.83% 62.58% 40.44% 4.58% -11.31% 10.20% 9.97% 0.72%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 89.17% 107.56%
Cost of Revenue to Revenue
94.02% 94.32% 94.63% 94.52% 94.80% 94.90% 95.03% 95.53% 95.85% 96.29% 96.39%
SG&A Expenses to Revenue
3.87% 3.75% 3.91% 3.94% 3.97% 3.71% 3.99% 2.81% 2.80% 2.37% 2.01%
R&D to Revenue
0.21% 0.17% 0.06% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
4.12% 2.09% 5.00% 5.07% 4.13% 7.21% 4.20% 2.88% 2.89% 2.48% 2.07%
Earnings before Interest and Taxes (EBIT)
3,603 7,199 644 1,068 2,501 -4,817 2,297 4,878 4,041 4,624 6,448
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4,488 8,109 1,595 2,017 3,423 -3,930 3,057 5,486 4,676 5,260 7,177
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.76 2.67 2.81 2.66 4.56 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.18 0.15 0.13 0.10 0.10 0.13 0.17 0.18 0.23 0.23 0.26
Price to Earnings (P/E)
14.87 5.83 411.57 633.80 25.82 0.00 40.72 13.63 23.47 25.60 22.26
Dividend Yield
0.74% 0.80% 0.97% 1.34% 1.23% 0.87% 0.60% 0.59% 0.33% 0.41% 0.37%
Earnings Yield
6.72% 17.14% 0.24% 0.16% 3.87% 0.00% 2.46% 7.34% 4.26% 3.91% 4.49%
Enterprise Value to Invested Capital (EV/IC)
2.70 2.29 2.37 2.25 2.86 14.18 61.77 0.00 0.00 0.00 64.00
Enterprise Value to Revenue (EV/Rev)
0.21 0.17 0.15 0.11 0.12 0.14 0.18 0.18 0.23 0.24 0.27
Enterprise Value to EBITDA (EV/EBITDA)
8.72 4.04 19.29 12.02 8.25 0.00 15.76 9.08 15.37 16.10 15.31
Enterprise Value to EBIT (EV/EBIT)
10.86 4.55 47.78 22.69 11.29 0.00 20.98 10.21 17.79 18.31 17.04
Enterprise Value to NOPAT (EV/NOPAT)
15.32 6.01 33.05 65.69 11.52 0.00 35.28 14.13 22.05 23.98 21.51
Enterprise Value to Operating Cash Flow (EV/OCF)
10.66 6.91 7.08 6.01 6.45 7.22 10.87 9.65 16.66 13.92 17.85
Enterprise Value to Free Cash Flow (EV/FCFF)
19.10 5.82 13.77 9.38 8.37 8.16 16.62 10.21 22.19 17.98 66.19
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.78 0.68 0.68 0.78 1.10 4.94 -3.28 -3.75 -3.52 -3.34 -7.82
Long-Term Debt to Equity
0.62 0.58 0.59 0.75 0.94 4.43 -2.83 -3.10 -3.49 -2.63 -6.31
Financial Leverage
0.43 0.25 0.13 0.12 0.26 0.49 -9.94 -1.06 -0.64 -0.31 -0.99
Leverage Ratio
5.55 5.11 5.03 5.66 7.38 15.48 -370.85 -38.27 -42.01 -43.30 -62.29
Compound Leverage Factor
5.01 4.89 1.87 3.24 3.37 16.18 -311.27 -36.33 -39.39 -40.82 -59.90
Debt to Total Capital
43.79% 40.41% 40.63% 43.97% 52.40% 83.17% 143.85% 136.31% 139.68% 142.78% 114.65%
Short-Term Debt to Total Capital
8.73% 5.86% 5.82% 1.91% 7.46% 8.63% 19.55% 23.59% 1.24% 30.08% 22.26%
Long-Term Debt to Total Capital
35.07% 34.55% 34.81% 42.06% 44.94% 74.54% 124.30% 112.72% 138.44% 112.70% 92.39%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
8.04% 7.12% 8.83% 9.18% 11.48% 17.07% 11.74% 8.94% 9.23% 9.60% 23.51%
Common Equity to Total Capital
48.16% 52.47% 50.55% 46.85% 36.12% -0.24% -55.59% -45.25% -48.91% -52.37% -38.16%
Debt to EBITDA
1.81 1.05 4.94 3.77 2.16 -1.82 1.92 1.02 1.20 1.07 0.91
Net Debt to EBITDA
0.91 0.21 0.93 0.55 0.99 -0.22 0.77 0.17 0.22 -0.01 0.36
Long-Term Debt to EBITDA
1.45 0.90 4.23 3.60 1.85 -1.63 1.66 0.84 1.19 0.85 0.73
Debt to NOPAT
3.18 1.57 8.46 20.59 3.02 -2.03 4.30 1.59 1.73 1.60 1.28
Net Debt to NOPAT
1.59 0.31 1.59 2.98 1.38 -0.25 1.72 0.26 0.32 -0.01 0.50
Long-Term Debt to NOPAT
2.54 1.34 7.25 19.69 2.59 -1.82 3.72 1.31 1.71 1.26 1.03
Altman Z-Score
4.30 4.34 4.13 4.22 4.45 3.91 4.87 5.36 5.62 5.87 6.16
Noncontrolling Interest Sharing Ratio
14.89% 13.01% 13.34% 15.56% 19.55% 37.83% -562.72% -25.81% -23.92% -22.84% -67.96%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.10 1.04 1.01 1.02 0.99 1.03 0.95 0.92 0.92 0.90 0.85
Quick Ratio
0.63 0.59 0.56 0.56 0.56 0.58 0.46 0.50 0.50 0.51 0.48
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2,049 5,635 2,234 2,584 3,371 4,019 2,899 4,879 3,239 4,709 1,660
Operating Cash Flow to CapEx
752.46% 1,174.26% 1,072.84% 947.42% 1,208.29% 1,007.10% 1,142.78% 1,322.82% 1,000.93% 1,133.15% 1,411.70%
Free Cash Flow to Firm to Interest Expense
5.80 18.30 5.52 9.79 13.54 18.52 7.86 19.67 12.85 17.77 6.72
Operating Cash Flow to Interest Expense
10.40 15.40 10.73 15.29 17.57 20.93 12.02 20.80 17.12 22.96 24.92
Operating Cash Flow Less CapEx to Interest Expense
9.02 14.09 9.73 13.67 16.11 18.85 10.96 19.23 15.41 20.94 23.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
3.46 3.38 3.43 3.57 3.82 3.77 4.11 4.41 4.76 5.04 5.12
Accounts Receivable Turnover
11.26 10.97 11.60 11.92 12.10 12.18 13.98 14.57 15.06 15.19 15.05
Inventory Turnover
12.11 12.23 12.48 12.27 13.10 12.57 13.22 13.77 14.51 15.67 16.48
Fixed Asset Turnover
88.31 86.89 87.62 85.52 94.06 96.33 112.98 129.64 137.53 149.05 156.07
Accounts Payable Turnover
6.68 6.28 6.24 6.14 6.17 5.94 6.51 6.56 6.61 6.75 6.75
Days Sales Outstanding (DSO)
32.41 33.27 31.47 30.62 30.17 29.98 26.11 25.06 24.24 24.02 24.26
Days Inventory Outstanding (DIO)
30.13 29.83 29.24 29.75 27.87 29.04 27.61 26.51 25.16 23.30 22.15
Days Payable Outstanding (DPO)
54.66 58.09 58.50 59.49 59.20 61.49 56.07 55.63 55.21 54.07 54.11
Cash Conversion Cycle (CCC)
7.88 5.02 2.21 0.88 -1.16 -2.47 -2.35 -4.06 -5.81 -6.74 -7.70
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
14,480 14,299 12,996 10,781 9,860 2,313 780 -574 -553 -1,731 1,717
Invested Capital Turnover
13.42 13.80 15.27 18.03 22.39 39.14 170.69 2,686.51 -548.27 -314.41 -57,632.86
Increase / (Decrease) in Invested Capital
506 -181 -1,303 -2,215 -921 -7,547 -1,533 -1,354 21 -1,178 3,448
Enterprise Value (EV)
39,136 32,776 30,767 24,236 28,228 32,788 48,184 49,790 71,888 84,686 109,885
Market Capitalization
33,580 29,572 27,575 21,549 23,237 30,451 45,357 48,507 70,470 84,343 105,996
Book Value per Share
$39.04 $52.32 $47.51 $42.19 $28.78 ($0.13) ($15.17) ($13.56) ($15.00) ($16.55) ($17.73)
Tangible Book Value per Share
($16.99) ($14.88) ($25.31) ($25.82) ($41.96) ($77.86) ($92.00) ($102.83) ($108.16) ($108.20) ($143.42)
Total Capital
18,528 21,145 19,396 17,275 14,098 8,594 4,087 4,104 4,030 3,960 5,692
Total Debt
8,114 8,545 7,880 7,595 7,387 7,148 5,879 5,594 5,629 5,654 6,526
Total Long-Term Debt
6,497 7,305 6,751 7,265 6,335 6,406 5,080 4,626 5,579 4,463 5,259
Net Debt
4,066 1,699 1,480 1,101 3,372 870 2,347 916 1,046 -37 2,551
Capital Expenditures (CapEx)
488 404 405 426 362 451 388 390 431 537 436
Debt-free, Cash-free Net Working Capital (DFCFNWC)
935 -207 -1,092 -1,812 -3,365 -4,257 -4,968 -7,375 -8,920 -10,706 -12,515
Debt-free Net Working Capital (DFNWC)
4,983 2,576 1,580 1,169 650 2,021 -1,436 -2,697 -4,337 -5,015 -8,540
Net Working Capital (NWC)
3,366 1,336 451 839 -402 1,279 -2,235 -3,665 -4,387 -6,206 -9,807
Net Nonoperating Expense (NNE)
245 301 634 114 1,330 812 79 -197 100 50 9.05
Net Nonoperating Obligations (NNO)
4,066 1,699 1,480 1,101 3,149 867 2,572 916 1,046 -37 2,551
Total Depreciation and Amortization (D&A)
885 910 951 949 922 887 760 608 635 636 729
Debt-free, Cash-free Net Working Capital to Revenue
0.49% -0.10% -0.52% -0.85% -1.46% -1.79% -1.88% -2.67% -2.89% -2.98% -3.10%
Debt-free Net Working Capital to Revenue
2.61% 1.30% 0.76% 0.55% 0.28% 0.85% -0.54% -0.97% -1.40% -1.40% -2.12%
Net Working Capital to Revenue
1.76% 0.67% 0.22% 0.39% -0.17% 0.54% -0.85% -1.32% -1.42% -1.73% -2.43%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$9.82 $22.95 $0.32 $0.17 $4.98 ($28.26) $7.32 $25.23 $22.54 $25.86 $38.55
Adjusted Weighted Average Basic Shares Outstanding
230M 221M 208M 196M 181M 160.60M 152.30M 141.10M 133.20M 127.40M 123.60M
Adjusted Diluted Earnings per Share
$9.70 $22.73 $0.32 $0.17 $4.95 ($28.26) $7.23 $25.03 $22.39 $25.72 $38.38
Adjusted Weighted Average Diluted Shares Outstanding
233M 223M 209M 197M 182M 160.60M 154.10M 142.20M 134.10M 128.10M 124.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.17 $4.98 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
225.02M 210.90M 202.05M 189.96M 161.85M 158.19M 145.37M 135.60M 129.99M 125.11M 120.20M
Normalized Net Operating Profit after Tax (NOPAT)
2,701 5,690 2,045 2,322 2,796 2,309 1,738 3,686 3,479 3,846 5,307
Normalized NOPAT Margin
1.41% 2.87% 0.98% 1.08% 1.21% 0.97% 0.66% 1.33% 1.13% 1.07% 1.32%
Pre Tax Income Margin
1.70% 3.47% 0.11% 0.28% 0.50% -2.11% 0.73% 1.67% 1.23% 1.21% 1.54%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.21 23.37 1.59 4.05 10.04 -22.20 6.22 19.67 16.04 17.45 26.11
NOPAT to Interest Expense
7.24 17.71 2.30 1.40 9.84 -16.26 3.70 14.21 12.94 13.33 20.68
EBIT Less CapEx to Interest Expense
8.82 22.06 0.59 2.43 8.59 -24.28 5.17 18.10 14.33 15.42 24.34
NOPAT Less CapEx to Interest Expense
5.85 16.40 1.30 -0.22 8.38 -18.34 2.65 12.64 11.23 11.30 18.92
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
10.56% 4.91% 88.22% 114.51% 26.25% -6.36% 21.52% 7.85% 9.94% 9.91% 7.47%
Augmented Payout Ratio
80.35% 49.76% 663.64% 757.25% 199.20% -24.59% 374.83% 105.59% 105.66% 100.29% 100.63%

Quarterly Metrics And Ratios for McKesson

This table displays calculated financial ratios and metrics derived from McKesson's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 122,487,456.00 120,204,051.00 116,590,363.00
DEI Adjusted Shares Outstanding
- - - - - - - - 122,487,456.00 120,204,051.00 116,590,363.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 13.73 5.11 10.45
Growth Metrics
- - - - - - - - - - -
Revenue Growth
10.80% 6.44% 21.29% 17.80% 18.95% 23.39% 10.14% 11.40% 6.02% 7.72% 7.57%
EBITDA Growth
20.31% 2.39% -31.66% 73.17% 21.35% -5.35% 113.81% 30.08% 39.22% 25.70% 12.49%
EBIT Growth
23.64% 1.85% -37.36% 91.27% 24.80% -5.09% 140.03% 30.94% 40.13% 25.91% 13.48%
NOPAT Growth
-0.68% -9.34% -57.44% 40.19% 58.99% -10.11% 277.60% 34.01% 36.84% 27.05% 13.46%
Net Income Growth
0.48% -3.71% -59.18% 47.30% 57.35% -13.44% 305.23% 34.70% 42.04% 24.19% 11.44%
EPS Growth
5.98% -0.28% -61.99% 57.24% 64.18% -10.71% 377.01% 37.99% 37.58% -17.60% 17.04%
Operating Cash Flow Growth
24.72% -31.18% 117.62% -1,038.19% 86.83% 33.48% 15.24% 151.70% -55.85% 76.03% 26.86%
Free Cash Flow Firm Growth
-62.13% 62.08% 725.71% -3,310.28% 202.93% -331.75% -206.11% 287.55% -161.63% 231.76% 269.82%
Invested Capital Growth
3.66% 9.36% -79.39% 87.56% -213.02% 130.33% 865.35% -16.23% 199.19% -27.40% -47.61%
Revenue Q/Q Growth
-5.62% 3.83% 18.12% 1.75% -4.69% 7.71% 5.44% 2.92% -9.29% 9.43% 5.29%
EBITDA Q/Q Growth
68.86% -5.82% -41.64% 86.58% 18.33% -26.53% 31.82% 13.52% 26.63% -33.67% 17.97%
EBIT Q/Q Growth
84.91% -7.28% -47.20% 111.27% 20.65% -29.49% 33.55% 15.25% 29.12% -36.64% 20.36%
NOPAT Q/Q Growth
30.53% 5.64% -65.91% 198.24% 48.03% -40.27% 43.20% 5.84% 51.17% -44.55% 27.88%
Net Income Q/Q Growth
31.75% 15.66% -70.10% 223.34% 40.73% -36.37% 39.95% 7.48% 48.40% -44.37% 25.58%
EPS Q/Q Growth
36.43% 16.09% -73.29% 271.66% 42.45% -36.87% 42.72% 7.51% 42.02% -62.19% 102.72%
Operating Cash Flow Q/Q Growth
1,532.68% -133.28% 252.17% -213.48% 425.14% -111.85% 363.62% -49.09% 177.68% -106.43% 1,495.45%
Free Cash Flow Firm Q/Q Growth
2,539.81% -11.57% 111.97% -164.88% 349.09% -167.65% 2.95% 214.67% -181.85% 244.65% 25.09%
Invested Capital Q/Q Growth
-124.83% 452.98% -83.15% 1,169.60% -141.44% 359.73% -29.36% 10.17% -50.93% 90.10% -49.02%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
4.70% 3.98% 3.47% 3.45% 4.01% 3.35% 3.43% 3.47% 4.20% 3.50% 3.57%
EBITDA Margin
1.85% 1.68% 0.83% 1.52% 1.88% 1.28% 1.61% 1.77% 2.47% 1.50% 1.68%
Operating Margin
1.59% 1.30% 0.62% 1.28% 1.75% 1.06% 1.36% 1.53% 2.23% 1.25% 1.45%
EBIT Margin
1.64% 1.46% 0.65% 1.36% 1.72% 1.12% 1.42% 1.59% 2.27% 1.31% 1.50%
Profit (Net Income) Margin
1.09% 1.21% 0.31% 0.97% 1.44% 0.85% 1.13% 1.18% 1.93% 0.98% 1.17%
Tax Burden Percent
70.94% 88.56% 53.75% 75.69% 86.20% 79.07% 83.37% 76.69% 87.29% 78.90% 82.97%
Interest Burden Percent
93.60% 93.53% 87.25% 94.82% 97.12% 95.55% 94.96% 96.28% 97.21% 94.44% 93.70%
Effective Tax Rate
29.06% 11.44% 46.25% 24.31% 13.80% 20.93% 16.63% 23.31% 12.71% 21.10% 17.03%
Return on Invested Capital (ROIC)
0.00% 193.01% 113.79% 104.63% 0.00% 98.07% 251.18% 121.27% 0.00% 104.60% 207.57%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 194.54% 113.01% 104.66% 0.00% 98.34% 250.88% 121.43% 0.00% 104.43% 206.48%
Return on Net Nonoperating Assets (RNNOA)
0.00% -471.91% -165.99% -257.46% 0.00% -380.92% -523.97% -453.96% 0.00% -478.91% -833.44%
Return on Equity (ROE)
-204.60% -278.90% -52.20% -152.84% -211.42% -282.85% -272.79% -332.70% -403.40% -374.30% -625.88%
Cash Return on Invested Capital (CROIC)
0.00% 160.68% 418.26% 33.72% 0.00% 27.54% 82.10% 137.53% 96.68% 169.13% 289.25%
Operating Return on Assets (OROA)
7.80% 6.76% 3.12% 6.80% 8.65% 5.55% 7.04% 8.17% 11.63% 6.37% 7.13%
Return on Assets (ROA)
5.18% 5.60% 1.46% 4.88% 7.24% 4.19% 5.57% 6.04% 9.87% 4.75% 5.54%
Return on Common Equity (ROCE)
-253.54% -357.22% -61.59% -179.01% -259.70% -469.15% -402.92% -520.11% -677.55% -1,073.62% -2,235.33%
Return on Equity Simple (ROE_SIMPLE)
0.00% -177.95% -89.72% -97.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
863 911 311 926 1,372 819 1,173 1,242 1,877 1,041 1,331
NOPAT Margin
1.13% 1.15% 0.33% 0.97% 1.51% 0.84% 1.14% 1.17% 1.95% 0.99% 1.20%
Net Nonoperating Expense Percent (NNEP)
3.33% -1.53% 0.78% -0.03% 12.99% -0.27% 0.30% -0.16% 1.74% 0.17% 1.08%
Return On Investment Capital (ROIC_SIMPLE)
- - - 17.45% 34.63% 13.24% 18.32% 21.95% 39.52% 17.74% 23.64%
Cost of Revenue to Revenue
95.30% 96.02% 96.53% 96.55% 95.99% 96.65% 96.57% 96.53% 95.80% 96.50% 96.43%
SG&A Expenses to Revenue
2.87% 2.52% 2.67% 2.13% 2.17% 2.24% 2.01% 1.91% 1.87% 2.15% 2.04%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
3.10% 2.68% 2.85% 2.16% 2.25% 2.29% 2.07% 1.95% 1.97% 2.25% 2.12%
Earnings before Interest and Taxes (EBIT)
1,250 1,159 612 1,293 1,560 1,100 1,469 1,693 2,186 1,385 1,667
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,410 1,328 775 1,446 1,711 1,257 1,657 1,881 2,382 1,580 1,864
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.23 0.24 0.19 0.21 0.23 0.24 0.25 0.25 0.26 0.22 0.24
Price to Earnings (P/E)
23.47 25.66 25.28 25.60 25.60 28.98 23.83 23.33 22.26 19.78 21.18
Dividend Yield
0.33% 0.32% 0.39% 0.47% 0.41% 0.39% 0.38% 0.37% 0.37% 0.43% 0.40%
Earnings Yield
4.26% 3.90% 3.96% 3.91% 3.91% 3.45% 4.20% 4.29% 4.49% 5.06% 4.72%
Enterprise Value to Invested Capital (EV/IC)
0.00 40.79 205.85 19.06 0.00 21.83 31.80 30.31 64.00 30.13 63.20
Enterprise Value to Revenue (EV/Rev)
0.23 0.25 0.21 0.23 0.24 0.26 0.26 0.27 0.27 0.24 0.25
Enterprise Value to EBITDA (EV/EBITDA)
15.37 16.92 15.58 16.05 16.10 18.91 16.64 16.30 15.31 13.11 13.65
Enterprise Value to EBIT (EV/EBIT)
17.79 19.60 18.32 18.45 18.31 21.50 18.63 18.21 17.04 14.60 15.17
Enterprise Value to NOPAT (EV/NOPAT)
22.05 25.12 24.55 26.28 23.98 28.60 23.57 23.05 21.51 18.45 19.16
Enterprise Value to Operating Cash Flow (EV/OCF)
16.66 19.98 13.22 32.05 13.92 14.99 14.71 10.12 17.85 14.35 14.02
Enterprise Value to Free Cash Flow (EV/FCFF)
22.19 26.52 16.82 73.73 17.98 110.54 70.20 20.09 66.19 14.98 15.02
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-3.52 -4.08 -2.17 -2.96 -3.34 -9.01 -13.42 -66.23 -7.82 -7.48 -9.06
Long-Term Debt to Equity
-3.49 -4.04 -2.15 -1.64 -2.63 -7.56 -10.40 -54.80 -6.31 -6.48 -8.28
Financial Leverage
-0.64 -2.43 -1.47 -2.46 -0.31 -3.87 -2.09 -3.74 -0.99 -4.59 -4.04
Leverage Ratio
-42.01 -51.80 -33.74 -31.37 -43.30 -68.17 -48.63 -55.39 -62.29 -78.39 -110.72
Compound Leverage Factor
-39.32 -48.45 -29.44 -29.75 -42.05 -65.14 -46.18 -53.33 -60.55 -74.03 -103.74
Debt to Total Capital
139.68% 132.46% 185.17% 150.94% 142.78% 112.48% 108.05% 101.53% 114.65% 115.44% 112.40%
Short-Term Debt to Total Capital
1.24% 1.20% 1.71% 67.63% 30.08% 18.06% 24.33% 17.53% 22.26% 15.39% 9.69%
Long-Term Debt to Total Capital
138.44% 131.26% 183.46% 83.31% 112.70% 94.42% 83.72% 84.00% 92.39% 100.05% 102.71%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
9.23% 8.79% 12.09% 7.16% 9.60% 15.97% 16.17% 18.57% 23.51% 34.87% 35.86%
Common Equity to Total Capital
-48.91% -41.26% -97.26% -58.10% -52.37% -28.45% -24.22% -20.10% -38.16% -50.31% -48.27%
Debt to EBITDA
1.20 1.20 1.32 1.62 1.07 1.50 1.28 1.01 0.91 1.30 1.19
Net Debt to EBITDA
0.22 0.71 0.74 1.39 -0.01 1.03 0.62 0.55 0.36 0.61 0.35
Long-Term Debt to EBITDA
1.19 1.19 1.31 0.89 0.85 1.26 0.99 0.83 0.73 1.12 1.09
Debt to NOPAT
1.73 1.78 2.08 2.64 1.60 2.27 1.81 1.43 1.28 1.83 1.68
Net Debt to NOPAT
0.32 1.05 1.17 2.27 -0.01 1.56 0.88 0.78 0.50 0.86 0.49
Long-Term Debt to NOPAT
1.71 1.76 2.06 1.46 1.26 1.90 1.40 1.18 1.03 1.58 1.53
Altman Z-Score
5.49 5.29 5.32 5.71 5.74 5.57 5.55 5.74 5.99 5.57 5.50
Noncontrolling Interest Sharing Ratio
-23.92% -28.08% -18.00% -17.12% -22.84% -65.86% -47.70% -56.33% -67.96% -186.83% -257.15%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.92 0.93 0.91 0.88 0.90 0.88 0.88 0.88 0.85 0.89 0.90
Quick Ratio
0.50 0.46 0.47 0.46 0.51 0.48 0.47 0.46 0.48 0.50 0.50
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
842 744 1,578 -1,024 2,550 -1,725 -1,674 1,920 -1,571 2,273 2,843
Operating Cash Flow to CapEx
2,205.85% -1,301.89% 1,544.12% -1,891.27% 4,584.62% -827.03% 2,283.02% 1,140.74% 3,081.98% -196.43% 4,723.08%
Free Cash Flow to Firm to Interest Expense
10.52 9.92 20.23 -15.28 56.66 -35.20 -22.62 30.47 -25.76 29.52 27.07
Operating Cash Flow to Interest Expense
51.84 -18.40 26.92 -35.57 172.18 -18.73 32.70 19.56 56.08 -2.86 29.24
Operating Cash Flow Less CapEx to Interest Expense
49.49 -19.81 25.18 -37.45 168.42 -21.00 31.27 17.84 54.26 -4.31 28.62
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
4.76 4.62 4.77 5.01 5.04 4.94 4.94 5.13 5.12 4.85 4.75
Accounts Receivable Turnover
15.06 13.76 13.83 14.09 15.19 14.55 14.46 14.73 15.05 14.06 14.17
Inventory Turnover
14.51 13.06 13.75 14.45 15.67 14.38 14.84 15.08 16.48 15.43 14.85
Fixed Asset Turnover
137.53 138.55 145.71 149.88 149.05 153.15 155.21 158.20 156.07 156.33 158.27
Accounts Payable Turnover
6.61 6.29 6.33 6.87 6.75 6.65 6.54 6.95 6.75 6.51 6.27
Days Sales Outstanding (DSO)
24.24 26.53 26.40 25.90 24.02 25.08 25.25 24.78 24.26 25.97 25.75
Days Inventory Outstanding (DIO)
25.16 27.96 26.55 25.26 23.30 25.38 24.59 24.20 22.15 23.65 24.59
Days Payable Outstanding (DPO)
55.21 58.06 57.63 53.09 54.07 54.91 55.85 52.48 54.11 56.03 58.22
Cash Conversion Cycle (CCC)
-5.81 -3.57 -4.68 -1.94 -6.74 -4.45 -6.01 -3.49 -7.70 -6.42 -7.88
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-553 1,952 329 4,177 -1,731 4,496 3,176 3,499 1,717 3,264 1,664
Invested Capital Turnover
-548.27 167.92 343.05 107.61 -314.41 117.12 220.88 103.69 -57,632.86 105.92 173.05
Increase / (Decrease) in Invested Capital
21 167 -1,267 1,950 -1,178 2,544 2,847 -678 3,448 -1,232 -1,512
Enterprise Value (EV)
71,888 79,624 67,725 79,605 84,686 98,143 101,007 106,043 109,885 98,330 105,164
Market Capitalization
70,470 75,917 64,115 72,344 84,343 91,680 96,092 101,246 105,996 90,826 99,546
Book Value per Share
($15.00) ($13.50) ($23.27) ($24.29) ($16.55) ($15.72) ($13.98) ($10.52) ($17.73) ($35.27) ($33.91)
Tangible Book Value per Share
($108.16) ($107.07) ($113.18) ($114.99) ($108.20) ($140.71) ($138.62) ($136.12) ($143.42) ($162.48) ($164.40)
Total Capital
4,030 4,254 3,102 5,308 3,960 6,914 7,180 6,458 5,692 8,428 8,192
Total Debt
5,629 5,635 5,744 8,012 5,654 7,777 7,758 6,557 6,526 9,729 9,208
Total Long-Term Debt
5,579 5,584 5,691 4,422 4,463 6,528 6,011 5,425 5,259 8,432 8,414
Net Debt
1,046 3,333 3,235 6,881 -37 5,359 3,754 3,598 2,551 4,565 2,680
Capital Expenditures (CapEx)
188 106 136 126 169 111 106 108 111 112 65
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-8,920 -6,433 -7,886 -4,362 -10,706 -8,699 -10,401 -10,261 -12,515 -11,386 -13,445
Debt-free Net Working Capital (DFNWC)
-4,337 -4,131 -5,377 -3,231 -5,015 -6,281 -6,397 -7,302 -8,540 -6,222 -6,917
Net Working Capital (NWC)
-4,387 -4,182 -5,430 -6,821 -6,206 -7,530 -8,144 -8,434 -9,807 -7,519 -7,711
Net Nonoperating Expense (NNE)
33 -49 24 -1.51 66 -12 10 -8.44 22 8.68 35
Net Nonoperating Obligations (NNO)
1,046 3,333 2,971 6,881 -37 5,359 3,754 3,598 2,551 4,565 2,680
Total Depreciation and Amortization (D&A)
160 169 163 153 151 157 188 188 196 195 197
Debt-free, Cash-free Net Working Capital to Revenue
-2.89% -2.05% -2.39% -1.27% -2.98% -2.30% -2.69% -2.58% -3.10% -2.77% -3.21%
Debt-free Net Working Capital to Revenue
-1.40% -1.32% -1.63% -0.94% -1.40% -1.66% -1.65% -1.83% -2.12% -1.51% -1.65%
Net Working Capital to Revenue
-1.42% -1.33% -1.64% -1.98% -1.73% -1.99% -2.10% -2.12% -2.43% -1.83% -1.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$6.07 $7.04 $1.88 $6.98 $9.96 $6.28 $8.95 $9.63 $13.69 $5.17 $10.47
Adjusted Weighted Average Basic Shares Outstanding
133.20M 129.80M 128.70M 126M 127.40M 124.90M 124M 123.20M 123.60M 118.70M 116.30M
Adjusted Diluted Earnings per Share
$6.03 $7.00 $1.87 $6.95 $9.90 $6.25 $8.92 $9.59 $13.62 $5.15 $10.44
Adjusted Weighted Average Diluted Shares Outstanding
134.10M 130.70M 129.30M 126.60M 128.10M 125.50M 124.40M 123.70M 124.10M 119.20M 116.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
129.99M 129.68M 126.94M 125.33M 125.11M 124.38M 123.43M 122.49M 120.20M 116.59M 115.46M
Normalized Net Operating Profit after Tax (NOPAT)
990 1,019 400 951 1,434 856 1,224 1,269 1,962 1,121 1,400
Normalized NOPAT Margin
1.30% 1.29% 0.43% 1.00% 1.58% 0.88% 1.19% 1.20% 2.04% 1.06% 1.26%
Pre Tax Income Margin
1.53% 1.37% 0.57% 1.29% 1.67% 1.07% 1.35% 1.54% 2.21% 1.24% 1.41%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
15.63 15.45 7.85 19.30 34.67 22.45 19.85 26.87 35.84 17.99 15.88
NOPAT to Interest Expense
10.78 12.15 3.98 13.83 30.48 16.72 15.85 19.71 30.77 13.52 12.67
EBIT Less CapEx to Interest Expense
13.28 14.04 6.10 17.42 30.91 20.18 18.42 25.16 34.02 16.53 15.26
NOPAT Less CapEx to Interest Expense
8.43 10.74 2.24 11.95 26.72 14.45 14.42 17.99 28.95 12.06 12.06
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
9.94% 10.31% 12.08% 11.18% 9.91% 10.53% 8.56% 8.15% 7.47% 7.42% 7.36%
Augmented Payout Ratio
105.66% 101.76% 142.81% 128.45% 100.29% 106.00% 68.31% 60.44% 100.63% 133.81% 132.06%

Financials Breakdown Chart

Key Financial Trends

McKesson’s recent results show rising revenue and stronger earnings, alongside uneven cash flow and a balance sheet with negative common equity. The figures below compare quarterly periods; the supplied data does not include every statement for every quarter.

  • Revenue has grown substantially. Revenue increased from $68.6 billion in Q3 FY2023 to $111.0 billion in Q2 FY2027. Comparing second quarters, it rose from $77.2 billion in FY2024 to $111.0 billion in FY2027, with year-over-year growth of about 7.6% in the latest quarter.
  • Profitability improved in Q2 FY2027. Gross profit reached $4.0 billion, up from $3.5 billion in Q2 FY2026, while operating income increased to $1.6 billion from $1.4 billion. Operating income has also recovered from the weaker $578 million reported in Q2 FY2025.
  • Latest-quarter earnings per share increased. Diluted EPS was $10.44 in Q2 FY2027, compared with $8.92 a year earlier. Net income attributable to common shareholders rose to $1.2 billion from $1.1 billion.
  • Cash generation rebounded, and cash rose. Operating cash flow was $3.1 billion in Q2 FY2027, versus negative $220 million in Q1. Cash and equivalents increased from $5.2 billion at the end of Q1 to $6.5 billion at the end of Q2.
  • Share repurchases have reduced the share count. Weighted-average diluted shares fell from 134.8 million in Q2 FY2024 to 116.7 million in Q2 FY2027, supporting per-share results. McKesson also repurchased $894 million of shares in Q2 FY2027, following $2.5 billion in Q1.
  • Operating cash flow can swing with working capital. Changes in operating assets and liabilities contributed $1.4 billion in Q2 FY2027, after using $1.7 billion in Q1. This reversal helps explain the sharp quarterly change in operating cash flow, but also makes cash generation less consistent from quarter to quarter.
  • Liquidity is tight on a conventional current-ratio measure. At the end of Q2 FY2027, current assets of $66.7 billion were below current liabilities of $74.4 billion. Much of the liability balance is accounts payable, a significant feature of pharmaceutical distribution, but the gap remains worth monitoring.
  • Common equity remains negative. McKesson reported negative common equity of $4.0 billion in Q2 FY2027, with treasury stock of negative $36.0 billion. This largely reflects accumulated share repurchases, but it leaves the balance sheet with less reported equity cushion.
  • Expenses and debt merit attention. Q2 FY2027 SG&A expense increased to $2.3 billion from $2.1 billion a year earlier, and the company recorded an $85 million restructuring charge. Total short- and long-term debt was about $9.2 billion at quarter-end, though that was down from approximately $9.7 billion in Q1 FY2027.

Overall, the data points to strong revenue growth and improving recent earnings, with share-count reduction adding support to EPS. Investors may also want to track cash flow across multiple quarters, alongside the company’s liquidity and negative common equity.

11/16/26 06:33 PM ETAI Generated. May Contain Errors.

McKesson Financials - Frequently Asked Questions

According to the most recent income statement we have on file, McKesson's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

McKesson's net income appears to be on an upward trend, with a most recent value of $5.10 billion in 2026, rising from $2.31 billion in 2016. The previous period was $3.48 billion in 2025. Check out McKesson's forecast to explore projected trends and price targets.

McKesson's total operating income in 2026 was $6.21 billion, based on the following breakdown:
  • Total Gross Profit: $14.55 billion
  • Total Operating Expenses: $8.34 billion

Over the last 10 years, McKesson's total revenue changed from $190.88 billion in 2016 to $403.43 billion in 2026, a change of 111.3%.

In the past 12 quarters, McKesson's cash and equivalents has ranged from $1.13 billion in Q3 2025 to $6.53 billion in Q2 2027, and is currently $6.53 billion as of their latest financial filing in Q2 2027.

McKesson had total debt of $6.53 billion at the end of 2026, a 15.4% increase from 2025, and a 19.6% decrease since 2016.

Over the last 10 years, McKesson's book value per share changed from 39.04 in 2016 to -17.73 in 2026.



Financial statements for NYSE:MCK last updated on 11/4/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners